Participated in Lumen Bioscience's $30M Series C extension for oral biologics platform using genetically engineered spirulina.
Lumen Bioscience has reinvented the production of biologic drugs using spirulina to deliver therapeutic proteins, aiming to make biologics more accessible and affordable
Lumen Bioscience has reinvented the production of biologic drugs using spirulina to deliver therapeutic proteins, aiming to make biologics more accessible and affordable.